CLXN (Calaxin/EFCAB1/ODAD5) is a Ca²⁺-binding protein essential for the function of motile cilia and flagella in vertebrates (PMID:31240264). It operates as the ODAD5 component of the outer dynein arm (ODA)-docking complex, where it stabilizes the attachment of outer arm dynein onto ciliary doublet microtubules; cryo-electron tomography shows that loss of Calaxin causes only partial OAD loss because the dynein remains tethered through other docking-complex subunits, and recombinant Calaxin autonomously rescues the deficient docking structure, establishing a discrete stabilizing role distinct from that of Armc4 (PMID:37057896). CLXN's incorporation into the axoneme depends on the integrity of the broader docking complex, as it is undetectable when ODAD1–ODAD4 are defective (PMID:36727596). Loss of CLXN function produces primary ciliary dyskinesia: in humans, pathogenic variants cause selective failure of distal ODA assembly with absence of DNAH5, DNAI1, and DNAI2 from distal axonemes and mislocalization of DNAH9 (PMID:36727596), while mouse and zebrafish nulls show hydrocephalus, situs inversus, and abnormal ciliary/flagellar beating with preserved 9+2 axonemal structure but disrupted 9+0 nodal cilia (PMID:31240264).